Jessica Wynn: Dialysis is a life-saving intervention but poses high infection risks, fewer than 40% of patients survive beyond five years, and the industry remains largely invisible | Jordan Harbinger

Dialysis patients face high infection risks and mortality rates in a $50 billion industry hidden from view.

Add us on Google by Editorial Team May. 31, 2026

Key takeaways

Dialysis is a life-saving intervention for kidney failure, but it also represents a massive, often invisible industry.
The dialysis process requires significant time commitment, akin to a part-time job for patients.
Diabetes and hypertension are the leading causes of kidney failure, accounting for 70% of cases.
Fewer than 40% of dialysis patients survive beyond five years, highlighting the severe nature of the treatment.
Dialysis does not replicate natural kidney function perfectly, resulting in fluctuating blood chemistry.
Infections pose a significant mortality risk for dialysis patients due to the need for vascular access.
Infection rates among dialysis patients are considerably higher than in the general population, varying widely between clinics.
The dialysis industry is valued at $50 billion, yet it remains largely out of public view.
Patients undergoing dialysis face a high risk of sepsis, with mortality rates 1 to 300 times higher than the general population.
Withdrawal from dialysis is a common cause of death, with 21% of patients choosing to stop treatment.
The dialysis process involves three sessions per week, each lasting three to five hours, until a transplant is possible or until death.
The variability in clinic infection rates underscores the importance of stringent safety protocols.

Guest intro

Jessica Wynn is a writer and researcher who contributes to The Jordan Harbinger Show, including its Skeptical Sunday episodes. She has explained complex topics such as memory and dialysis for the show, bringing a clear, research-driven perspective to difficult subjects.

Why dialysis is both a medical miracle and a hidden industry

Dialysis is essential for patients with kidney failure, cleansing the blood when kidneys fail. – Jessica Wynn
Dialysis operates in this weird space where it’s simultaneously a genuine medical miracle and a massive industry but you don’t see it until you’re inside it

— Jessica Wynn
The dialysis industry is valued at $50 billion, yet it remains largely out of public view.
Dialysis is crucial for about 800,000 Americans living with kidney failure. – Jessica Wynn
The process involves significant time commitment, akin to a part-time job for patients.
You’re getting a part time job filtering your blood… fifteen hours a week and that’s minimum and that’s fifty two weeks a year.
Advertisement

— Jessica Wynn
Despite its life-saving nature, fewer than 40% of dialysis patients survive more than five years.
The dual nature of dialysis as a treatment and industry highlights systemic issues prioritizing profit over patient outcomes.

The burden of dialysis treatment on patients’ lives

Dialysis requires three sessions per week, each lasting three to five hours. – Jessica Wynn
So dialysis is an external version of that filtration system… typically three to five hours per session… three times a week… until you get a transplant or you know you die.

— Jessica Wynn
The extensive time commitment frames dialysis as a significant lifestyle impact for patients.
Dialysis can be considered a part-time job due to the time involved. – Jessica Wynn
You’re getting a part time job filtering your blood… fifteen hours a week and that’s minimum and that’s fifty two weeks a year.

— Jessica Wynn
This time commitment affects patients’ ability to manage other aspects of their lives.
The burden of dialysis extends beyond the physical, impacting mental and emotional well-being.
The treatment’s demands highlight the need for comprehensive patient support systems.

The leading causes and risks of kidney failure

Diabetes and hypertension are the primary causes of kidney failure, accounting for 70% of cases. – Jessica Wynn
The two biggest causes are diabetes and hypertension and together they account for about seventy percent of kidney failure cases

— Jessica Wynn
Understanding these risk factors is crucial for prevention and management strategies.
Fewer than 40% of dialysis patients survive beyond five years, comparable to cancer statistics. – Jessica Wynn
The serious health risks associated with dialysis challenge common perceptions of it as a routine treatment.
Dialysis does not function as effectively as natural kidneys, leading to fluctuating blood chemistry. – Jessica Wynn
Natural kidneys work continuously and are perfectly calibrated so dialysis happens three times a week so you get this sawtooth patterns in your blood chemistry

— Jessica Wynn
The limitations of dialysis underscore the importance of early intervention and management of risk factors.

The high infection risk in dialysis patients

Infections are a leading cause of death among dialysis patients, significantly increasing mortality risk. – Jessica Wynn
Infections are responsible for thirty six percent of all dialysis deaths and the most common cause of death after that withdrawal from dialysis…

— Jessica Wynn
The need for vascular access in dialysis increases infection risk. – Jessica Wynn
It’s horrific but dialysis requires vascular access so either a fistula… or a catheter is used and every time you stick needles in someone or have a catheter line going into their bloodstream you create an infection risk

— Jessica Wynn
Patients face a high risk of sepsis, with mortality rates 1 to 300 times higher than the general population. – Jessica Wynn
The high infection rates highlight the need for improved safety protocols in clinics.
Infection rates vary widely between clinics, emphasizing the importance of consistent care standards.
The variability in infection rates underscores the need for stringent safety protocols in dialysis clinics.

The variability of care quality across dialysis clinics

Infection rates in dialysis patients are significantly higher than in those not on dialysis. – Jessica Wynn
Bloodstream infections from staph bacteria occur a 100 times more often in dialysis patients than in adults not on dialysis…

— Jessica Wynn
Infection rates vary widely between clinics, with some having excellent protocols and others being “infection factories.” – Jessica Wynn
The inconsistency in care quality poses significant health risks for patients.
Clinics with poor infection control contribute to higher mortality rates among patients.
The variability in care quality highlights systemic issues within the dialysis industry.
Addressing these inconsistencies is crucial for improving patient outcomes.
The need for stringent safety protocols is underscored by the wide variation in infection rates across clinics.

The systemic issues in the dialysis industry

The dialysis industry is valued at $50 billion, yet it remains largely out of public view.
Despite its life-saving nature, fewer than 40% of dialysis patients survive more than five years.
The dual nature of dialysis as a treatment and industry highlights systemic issues prioritizing profit over patient outcomes.
Patients face significant health risks, including high infection rates and mortality.
The variability in care quality across clinics underscores systemic issues within the industry.
Addressing these issues is crucial for improving patient outcomes and ensuring equitable care.
The industry’s focus on profit over patient care needs to be addressed for meaningful reform.
The staggering costs and risks associated with dialysis highlight the need for systemic change in the healthcare industry.

The need for healthcare reform and patient advocacy

The dialysis industry highlights systemic issues that prioritize profit over patient outcomes.
Patients face significant health risks, including high infection rates and mortality.
The variability in care quality across clinics underscores systemic issues within the industry.
Addressing these issues is crucial for improving patient outcomes and ensuring equitable care.
The industry’s focus on profit over patient care needs to be addressed for meaningful reform.
The staggering costs and risks associated with dialysis highlight the need for systemic change in the healthcare industry.
Patient advocacy is crucial for driving reform and ensuring that patient needs are prioritized.
Comprehensive support systems are needed to address the physical, mental, and emotional burdens of dialysis.

The importance of early intervention and prevention

Diabetes and hypertension are the primary causes of kidney failure, accounting for 70% of cases. – Jessica Wynn
Understanding these risk factors is crucial for prevention and management strategies.
Early intervention can help manage risk factors and prevent the progression to kidney failure.
Comprehensive management of diabetes and hypertension is essential for preventing kidney failure.
Public awareness and education about risk factors can aid in prevention efforts.
Early detection and management of kidney disease can improve patient outcomes and reduce the need for dialysis.
Prevention strategies can help reduce the burden on the healthcare system and improve patient quality of life.
Addressing the root causes of kidney failure is crucial for reducing the incidence and impact of the disease.

The future of dialysis and kidney care

The dialysis industry is valued at $50 billion, yet it remains largely out of public view.
Despite its life-saving nature, fewer than 40% of dialysis patients survive more than five years.
The dual nature of dialysis as a treatment and industry highlights systemic issues prioritizing profit over patient outcomes.
Patients face significant health risks, including high infection rates and mortality.
The variability in care quality across clinics underscores systemic issues within the industry.
Addressing these issues is crucial for improving patient outcomes and ensuring equitable care.
The industry’s focus on profit over patient care needs to be addressed for meaningful reform.
The staggering costs and risks associated with dialysis highlight the need for systemic change in the healthcare industry.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.